Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor

Technology appraisal guidance
Reference number: TA195
Published: 25 August 2010

Rheumatoid arthritis - drugs for treatment after failure of a TNF inhibitor: consultee and commentator comments on the ACD

Rheumatoid arthritis - drugs for treatment after failure of a TNF inhibitor: additional analysis - supplementary data including a continuation rule as in Roche model
Rheumatoid arthritis - drugs for treatment after failure of a TNF inhibitor: manufacturer/sponsor
Rheumatoid arthritis - drugs for treatment after failure of a TNF inhibitor: professional and patient groups
Rheumatoid arthritis - drugs for treatment after failure of a TNF inhibitor: comments from website consultation

This page was last updated: 24 June 2010